W. MARK WATSON

Corporate Board Profile

Tech Score: 0/100

Vaxart, Inc.

Filing Date	Source Excerpt
2023-04-28	W. Mark Watson has served as a member of our board of directors since August 2022. Mr. Watson is a Certified Public Accountant with over 40 years of experience in public accounting and auditing. He has served as lead audit partner and lead client service partner on public companies ranging from middle market firms to Fortune 500 enterprises. Mr. Watson also served as Chairman of the Board of Directors and Chairman of the Audit Committee of Inhibitor Therapeutics, Inc. and as a director and member of the Audit Committee of Sykes Enterprises, Inc and BioDelivery Sciences International, Inc. Mr. Watson serves as a trustee of Tekla World Healthcare Fund and other funds since June 2022. Mr. Watson also serves on the Board of Moffitt Cancer Center and as its Audit Committee Chair. He received his undergraduate degree in Accounting from Marquette University. The following table provides director compensation information for each of the non-employee directors of the board of directors who served between January 1, 2022 and December 31, 2022: W. Mark Watson Fees Earned or Paid in Cash: $22,724, Stock Awards: $57,673, Option Awards: $308,232, Total: $388,629.
2024-04-29	W. Mark Watson has served as a member of our board of directors since August 2022.

Filing Date

Source Excerpt

2023-04-28

W. Mark Watson has served as a member of our board of directors since August 2022. Mr. Watson is a Certified Public Accountant with over 40 years of experience in public accounting and auditing. He has served as lead audit partner and lead client service partner on public companies ranging from middle market firms to Fortune 500 enterprises. Mr. Watson also served as Chairman of the Board of Directors and Chairman of the Audit Committee of Inhibitor Therapeutics, Inc. and as a director and member of the Audit Committee of Sykes Enterprises, Inc and BioDelivery Sciences International, Inc. Mr. Watson serves as a trustee of Tekla World Healthcare Fund and other funds since June 2022. Mr. Watson also serves on the Board of Moffitt Cancer Center and as its Audit Committee Chair. He received his undergraduate degree in Accounting from Marquette University. The following table provides director compensation information for each of the non-employee directors of the board of directors who served between January 1, 2022 and December 31, 2022: W. Mark Watson Fees Earned or Paid in Cash: $22,724, Stock Awards: $57,673, Option Awards: $308,232, Total: $388,629.

2024-04-29

W. Mark Watson has served as a member of our board of directors since August 2022.

Data sourced from SEC filings. Last updated: 2025-07-01